• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Brooklyn ImmunoTherapeutics, Inc. - Common Stock (NY:BTX)

8.440 -0.290 (-3.32%)
Official Closing Price Updated: 7:00 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 545,861
Open 8.430
Bid (Size) 8.300 (100)
Ask (Size) 8.600 (500)
Prev. Close 8.730
Today's Range 8.390 - 8.595
52wk Range 6.130 - 9.490
Shares Outstanding 7,848,889
Dividend Yield 7.46%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
September 30, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
September 10, 2026
From BlackRock Closed-End Funds
Via Business Wire

Performance

52-Week Range 11.1% below 52-week high
8.440
6.1352W Low 9.4952W High
1 Week 3.4% below 1-week high
8.391W Low 8.741W High

Brooklyn ImmunoTherapeutics, Inc. - Common Stock (BTX) traded between $6.13 and $9.49 over the past 52 weeks and last traded at $8.44, 11.1% below its 52-week high. Over the past week it ranged between $8.39 and $8.74.

Past 12 Months
-0.4%
-6.7%
+1.2%
+10.6%
+26.2%
+29.6%
1W -$0.03
1M -$0.61
3M +$0.10
6M +$0.81
YTD +$1.75
1Y +$1.93

BTX was +29.6% over the past year, +10.6% over six months, +26.2% year to date, -0.4% in the last week.

12 Months vs Market
BTX
+29.6%
DIA
+13.3%
SPY
+14.4%
QQQ
+16.3%
IWM
+13.7%

Over the past 12 months BTX returned +29.6% versus DIA (Dow) +13.3%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 1.15× 3-mo avg
Today 545,861 3-mo avg 475.7K
1W
480.3K
1M
517.4K
3M
475.7K
6M
613.4K
YTD
698.0K
1Y
745.9K

BTX most recently traded 545,861 shares against a 3-month average daily volume of 475.7K.

More News

Read More
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
August 31, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
July 31, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
June 30, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
June 05, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
May 29, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
April 30, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
March 31, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
February 27, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
February 27, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
BlackRock Technology and Private Equity Term Trust Maintains Payouts, But Return of Capital Raises Investor Eyebrows
October 02, 2025
Via MarketMinute
Topics Initial Public Offering
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
January 30, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
January 02, 2026
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
December 31, 2025
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
December 12, 2025
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
November 28, 2025
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
November 03, 2025
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
October 31, 2025
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
October 01, 2025
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
September 30, 2025
From BlackRock Closed-End Funds
Via Business Wire
News headline image
BlackRock Announces Update to BMEZ, BSTZ, and BTX Managed Distribution Plans
September 11, 2025
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Sector Equity Closed-End Funds Announce Updates to Investment Objectives and Principal Investment Strategies
September 10, 2025
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
September 02, 2025
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
August 29, 2025
From BlackRock Closed-End Funds
Via Business Wire

Frequently Asked Questions

Is Brooklyn ImmunoTherapeutics, Inc. - Common Stock publicly traded?
Yes, Brooklyn ImmunoTherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Brooklyn ImmunoTherapeutics, Inc. - Common Stock trade on?
Brooklyn ImmunoTherapeutics, Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The ticker symbol for Brooklyn ImmunoTherapeutics, Inc. - Common Stock is BTX on the New York Stock Exchange
What is the current price of Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The current price of Brooklyn ImmunoTherapeutics, Inc. - Common Stock is 8.440
When was Brooklyn ImmunoTherapeutics, Inc. - Common Stock last traded?
The last trade of Brooklyn ImmunoTherapeutics, Inc. - Common Stock was at 10/22/26 07:00 PM ET
What is the market capitalization of Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The market capitalization of Brooklyn ImmunoTherapeutics, Inc. - Common Stock is 66.24M
How many shares of Brooklyn ImmunoTherapeutics, Inc. - Common Stock are outstanding?
Brooklyn ImmunoTherapeutics, Inc. - Common Stock has 66M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap